MT 007A
Alternative Names: MT-007A; MTL-007ALatest Information Update: 05 Feb 2024
At a glance
- Originator Merakris Therapeutics
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Wounds
Most Recent Events
- 19 Dec 2023 Early research in Wounds in USA (unspecified route) prior to December 2023 (Merakris Therapeutics pipeline, December 2023)